Company news

IceCure Medical Ltd. news in 2021

IceCure Medical Ltd.'s news releases, calls and decks from 2021, newest first.

View company

IceCure Medical Ltd. Closes $17 Million Underwritten Public Offering and Partial Exercise of Over-Allotment Option

December 12, 2021

IceCure Medical Ltd. Announces Pricing of $15 Million Underwritten Public Offering

December 8, 2021

IceCure Medical Announces Appointment of Merav Nir Dotan to Vice President Human Resources

November 28, 2021

IceCure Medical Reports Financial Results as of and for the first Nine Months of 2021 and Recent Corporate Developments

November 22, 2021

IceCure Medical Announces New Independent Data Published in the Journal of Cancer Therapy Showing that Percutaneous Cryoablation Presents a Potential Substitute for Lumpectomy for Tumors <15mm using ProSense™

October 31, 2021

IceCure Medical Enters into an Exclusive Agreement in Poland for Distribution of the ProSense™ Cryoablation System

October 19, 2021

IceCure Medical Announces Updated Regulatory Strategy in China for the IceSense3® System to Treat Cancerous Tumors with Cryoablation

October 11, 2021

IceCure Medical Announces First Peer Reviewed Publication for the 3-Year Interim Analysis of the ICE3 Trial on Cryoablation of Low-Risk, Early-Stage Breast Cancer

September 12, 2021

IceCure Medical Announces Exclusive Distribution Agreement to Sell ProSense™ Cryoablation System in Turkey

August 31, 2021

IceCure Medical Shares to Begin Trading on Nasdaq Capital Market on August 26, 2021

August 25, 2021

Decks in 2021